Production of reactive oxygen species in peripheral blood is increased in individuals with Helicobacter pylori infection and decreased after its eradication

Helicobacter

Volumn 11, Issue 4, 2006, Pages 266-271

  Mashimo, Masayuki ^a   Nishikawa, Manabu ^a   Higuchi, Kazuhide ^a   Hirose, Masaki ^a   Wei, Qian ^a   Haque, Anwarul ^a   Sasaki, Eiji ^a   Shiba, Masatsugu ^a   Tominaga, Kazunari ^a   Watanabe, Toshio ^a   Fujiwara, Yasuhiro ^a   Arakawa, Tetsuo ^a   Inoue, Masayasu ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Eradication; Helicobacter pylori; Oxidative stress; Peripheral blood

Indexed keywords

AMOXICILLIN; C REACTIVE PROTEIN; CLARITHROMYCIN; PROTON PUMP INHIBITOR; PYRIDAZINE DERIVATIVE; RANSOPRAZOLE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BACTERIAL INFECTION; BLOOD ANALYSIS; BLOOD LEVEL; BLOOD SAMPLING; CHEMOLUMINESCENCE; CORRELATION ANALYSIS; FEMALE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; SEX; SMOKING;

ADULT; AGE FACTORS; AGED; ALCOHOL DRINKING; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHEMILUMINESCENT MEASUREMENTS; FEMALE; HELICOBACTER INFECTIONS; HUMANS; MALE; MIDDLE AGED; REACTIVE OXYGEN SPECIES; SEX FACTORS; SMOKING;

HELICOBACTER PYLORI;

EID: 33745911139     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2006.00410.x     Document Type: Article

References (35)

1. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175-86.
2. Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt RH. Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 2003;125:1636-44.
3. Yamagata H, Kiyohara Y, Aoyagi K, et al. Impact of Helicobacter pylori infection on gastric cancer incidence in a general Japanese population: the Hisayama study. Arch Intern Med 2000;160:1962-8.
4. Uemura N, Okamoto S, Yamamoto S, Matsumnara N, Yamaguchi S, Yamakido K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
5. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 1998;352:878.
6. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm AJ, Northfield TC. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994;71:437-9.
7. Farsak B, Yildirir A, Akyon Y, Pinar A, Oc M, Boke E, Kes S, Tokgozoghu L. Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR. J Clin Microbiol 2000;38:4408-11.
8. Ameriso SF, Fridman EA, Leiguarda RC, Sevlever GE. Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke 2001;32:385-91.
9. Rebora A, Drago F, Parodi A. May Helicobacter pylori be important for dermatologists? Dermatology 1995;191:6-8.
10. Simon L, Tornoczky J, Toth M, Jambor M, Sudar Z. [The significance of Campylobacter pylori infection in gastroenterologic and diabetic practice]. Orv Hetil 1989;130:1325-9.
11. Gasbarrini A, Gabrielli M, Fiore G, et al. Association between Helicobacter pylori cytotoxic type I CagA-positive strains and migraine with aura. Cephalalgia 2000;20:561-5.
12. Chiba S, Sugiyama T, Yonekura K, Tanaka S, Matsumoto H, Fujii N, Ebisu S, Sekiguchi K. An antibody to VacA of Helicobacter pylori in cerebrospinal fluid from patients with Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 2002;73:76-8.
13. Seriolo B, Cutolo M, Zentilin P, Savarino V. Helicobacter pylori infection in rheumatoid arthritis. J Rheumatol 2001;28:1195-6.
14. Tebbe B, Geilen CC, Schulzke JD, Bojarski C, Radenhausen M, Orfanos CE. Helicobacter pylori infection and chronic urticaria. J Am Acad Dermatol 1996;34:685-6.
15. Mai UE, Perez-Perez GI, Wahl LM, Wahl SM, Blaser MJ, Smith PD. Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J Clin Invest 1991;87:894-900.
16. Drake IM, Mapstone NP, Schorah CJ, White KL, Chalmers DM, Dixon MF, Axon AT. Reactive oxygen species activity and lipid peroxidation in Helicobacter pylori-associated gastritis: relation to gastric mucosal ascorbic acid concentrations and effect of H. pylori eradication. Gut 1998;42:768-71.
17. Pignatelli B, Bancel B, Plummer M, Toyokuni S, Patricot LM, Ohshima H. Helicobacter pylori eradication attenuates oxidative stress in human gastric mucosa. Am J Gastroenterol 2001;96:1758-66.
18. Misra HP, Squatrito PM. The role of superoxide anion in peroxidase-catalyzed chemiluminescence of luminol. Arch Biochem Biophys 1982;215:59-65.
19. Allen RC. Phagocytic leukocyte oxygenation activities and chemiluminescence: a kinetic approach to analysis. Methods Enzymol 1986;133:449-93.
20. -. Clin Chim Acta 1989;179:177-81.
21. DeChatelet LR, Shirley PS. Evaluation of chronic granulomatous disease by a chemiluminescence assay of microliter quantities of whole blood. Clin Chem 1981;27:1739-41.
22. Nakano M. Determination of superoxide radical and singlet oxygen based on chemiluminescence of luciferin analogs. Methods Enzymol 1990;186:585-91.
23. Nishinaka Y, Aramaki Y, Yoshida H, Masuya H, Sugawara T, Ichimori Y. A new sensitive chemiluminescence probe, L-012, for measuring the production of superoxide anion by cells. Biochem Biophys Res Commun 1993;193:554-9.
24. Imada I, Sato EF, Miyamoto M, Ichimori Y, Minamiyama Y, Konaka R, Inoue M. Analysis of reactive oxygen species generated by neutrophils using a chemiluminescence probe L-012. Anal Biochem 1999;271:53-8.
25. Kukovetz EM, Bratschitsch G, Hofer HP, Egger G, Schaur RJ. Influence of age on the release of reactive oxygen species by phagocytes as measured by a whole blood chemiluminescence assay. Free Radic Biol Med 1997;22:433-8.
26. Pansarasa O, Castagna L, Colombi B, Vecchiet J, Felzani G, Marzatico F. Age and sex differences in human skeletal muscle: role of reactive oxygen species. Free Radic Res 2000;33:287-93.
27. van Antwerpen VL, Theron AJ, Richards GA, Steenkamp KJ, van der Merwe CA, van der Walt R, Anderson R. Vitamin E, pulmonary functions, and phagocyte-mediated oxidative stress in smokers and nonsmokers. Free Radic Biol Med 1995;18:935-41.
28. Patel M, Keshavarzian A, Kottapalli V, Badie B, Winship D, Fields JZ. Human neutrophil functions are inhibited in vitro by clinically relevant ethanol concentrations. Alcohol Clin Exp Res 1996;20:275-83.
29. Jones-Blackett S, Hull MA, Davies GR, Crabtree JE. Non-steroidal anti-inflammatory drugs inhibit Helicobacter pylori-induced human neutrophil reactive oxygen metabolite production in vitro. Aliment Pharmacol Ther 1999;13:1653-61.
30. Munakata W, Liu Q, Shimoyama T, Sawaya M, Umeda T, Sugawara K. Ecabet sodium attenuates reactive oxygen species produced by neutrophils after priming with bacterial lipopolysaccharides. Luminescence 2003;18:330-3.
31. Oldenburg B, van Kats-Renaud H, Koningsberger JC, van Berge Henegouwen GP, van Asbeck BS. Chemiluminescence in inflammatory bowel disease patients: a parameter of inflammatory activity. Clin Chim Acta 2001;310:151-6.
32. Moriwaki Y, Sugiyama M, Ozawa Y, Mochizuki Y, Kunisaki C, Kamiya N, Yamazaki Y, Suda T. Changes in the response of neutrophils to endotoxin priming following major abdominal surgery. World J Surg 2002;26:521-6.
33. Saito D, Nakaji S, Umeda T, Kurakake S, Danjo K, Shimoyama T, Sugawara K. Effects of long-distance running on serum opsonic activity measured by chemiluminescence. Luminescence 2003;18:122-4.
34. Cutler AF, Prasad VM. Long-term follow-up of Helicobacter pylori serology after successful eradication. Am J Gastroenterol 1996;91:85-8.
35. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161-81.